Numerous studies have shown that EV-miRNAs can influence the PD-1/PD-L1 pathway through both direct and indirect mechanisms in various cancers, such as CRC, glioma, GC (GC), acute myeloid leukemia (AML), and melanoma. This evidence concerns the gene PDCD1 and melanoma.